Compare ImmunityBio Inc. Common Stock (IBRX) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Oscar Health Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.7 (market cap $10.51B), while Oscar Health Inc trades at $33.26 (market cap $10.22B). The key difference: ImmunityBio Inc. Common Stock and Oscar Health Inc are close in size by market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 4,123,394). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Oscar Health Inc for 15 Days on average.
| IBRX | OSCR | |
|---|---|---|
Market Cap | $10.51B | $10.22B |
Volume | 10,445,785 | 4,123,394 |
Sector | Health | Health |
52-Week High | $11.55 | $33.81 |
52-Week Low | $1.98 | $10.85 |
Typical Hold Time | 1 Days | 15 Days |
Enterprise Value | $10.97B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.
The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
